BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Kalydeco (Ivacaftor) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Kalydeco (Ivacaftor)\, from ClinicalTrial
 s.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT03439865-10840@assetmemo.bio
DTSTAMP:20261121T005717Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Kalydeco (Ivacaftor): Phase 1 readout est. (NCT03439865)
DESCRIPTION:Kalydeco (Ivacaftor)\, phase 1.\nStudy: Ivacaftor for Acquired 
 CFTR Dysfunction in Chronic Rhinosinusitis\nEstimated primary completion: 
 April 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/ivacaftor
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT034
 39865
URL:https://assetmemo.bio/drug/ivacaftor#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
